UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
$1.65B |
| 2 |
Accenture
ACN
|
$1.54B |
| 3 |
Linde
LIN
|
$1.24B |
| 4 |
Prologis
PLD
|
$1.08B |
| 5 |
Microsoft
MSFT
|
$914M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$809M |
| 2 |
Blackrock
BLK
|
$809M |
| 3 |
Lam Research
LRCX
|
$735M |
| 4 |
Meta Platforms (Facebook)
META
|
$563M |
| 5 |
UBS Group
UBS
|
$411M |
Sector Composition
| 1 | Technology | 33.21% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Methode Electronics
MEI
$250M
| $909K | ﹤0.01% |
75,971
+3,288
| +5% | +$39.3K |
|
2402
Day One Biopharmaceuticals
DAWN
$773M
| $908K | ﹤0.01% |
65,193
-4,537
| -7% | -$63.2K |
|
|
HAYN
2403
DELISTED
Haynes International, Inc.
HAYN
| $908K | ﹤0.01% |
15,245
-345
| -2% | -$20.5K |
|
2404
Olema Pharmaceuticals
OLMA
$570M
| $907K | ﹤0.01% |
75,974
-7,616
| -9% | -$90.9K |
|
2405
Pharvaris
PHVS
$1.48B
| $906K | ﹤0.01% |
+48,896
| New | +$906K |
|
|
PTVE
2406
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $903K | ﹤0.01% |
78,450
-21,078
| -21% | -$243K |
|
|
BFS
2407
Saul Centers
BFS
$812M
| $903K | ﹤0.01% |
21,515
+5,073
| +31% | +$213K |
|
2408
NETGEAR
NTGR
$811M
| $902K | ﹤0.01% |
44,967
-1,622
| -3% | -$32.5K |
|
2409
HarborOne Bancorp
HONE
$560M
| $902K | ﹤0.01% |
69,488
-13,416
| -16% | -$174K |
|
2410
Opko Health
OPK
$1.07B
| $902K | ﹤0.01% |
605,058
-149,104
| -20% | -$222K |
|
2411
Donegal Group Class A
DGICA
$689M
| $896K | ﹤0.01% |
60,767
+17,125
| +39% | +$252K |
|
2412
CEVA Inc
CEVA
$543M
| $893K | ﹤0.01% |
36,962
-2,642
| -7% | -$63.8K |
|
2413
Daily Journal
DJCO
$676M
| $891K | ﹤0.01% |
1,818
-190
| -9% | -$93.1K |
|
2414
Bristow Group
VTOL
$1.09B
| $891K | ﹤0.01% |
25,679
+6,723
| +35% | +$233K |
|
2415
Haverty Furniture Companies
HVT
$390M
| $890K | ﹤0.01% |
32,406
-1,084
| -3% | -$29.8K |
|
2416
Liberty Latin America Class A
LILA
$1.6B
| $890K | ﹤0.01% |
92,857
+54,787
| +144% | +$525K |
|
2417
Replimune Group
REPL
$494M
| $890K | ﹤0.01% |
81,164
-6,759
| -8% | -$74.1K |
|
|
NAPA
2418
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $888K | ﹤0.01% |
152,823
-10,131
| -6% | -$58.9K |
|
2419
Hertz
HTZ
$1.7B
| $885K | ﹤0.01% |
268,259
+25,885
| +11% | +$85.4K |
|
2420
York Water
YORW
$447M
| $882K | ﹤0.01% |
23,544
-4,380
| -16% | -$164K |
|
2421
Pacific Biosciences
PACB
$381M
| $873K | ﹤0.01% |
513,801
-84,929
| -14% | -$144K |
|
2422
Nu Skin
NUS
$569M
| $858K | ﹤0.01% |
116,424
+4,125
| +4% | +$30.4K |
|
2423
National Research Corp
NRC
$355M
| $855K | ﹤0.01% |
37,417
-11,863
| -24% | -$271K |
|
2424
Denny's
DENN
$237M
| $855K | ﹤0.01% |
132,548
-11,188
| -8% | -$72.2K |
|
|
ONC
2425
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $850K | ﹤0.01% |
3,786
-1,021
| -21% | -$229K |
|